These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 15125479)

  • 1. Specificity of anti-sp100 antibody for primary biliary cirrhosis.
    Bogdanos DP; Vergani D; Muratori P; Muratori L; Bianchi FB
    Scand J Gastroenterol; 2004 Apr; 39(4):405-6; author reply 407. PubMed ID: 15125479
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-sp100 antibodies in primary biliary cirrhosis.
    Rigopoulou EI; Dalekos GN
    Scand J Gastroenterol; 2004 Apr; 39(4):406-7; author reply 407. PubMed ID: 15125480
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical significance of anti-multiple nuclear dots/Sp100 autoantibodies.
    Wichmann I; Montes-Cano MA; Respaldiza N; Alvarez A; Walter K; Franco E; Sanchez-Roman J; Núñez-Roldán A
    Scand J Gastroenterol; 2003 Sep; 38(9):996-9. PubMed ID: 14531539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunologic tests: Anti-Sp100 antibody].
    Mori S; Wake H; Takahashi HK; Nishibori M
    Nihon Rinsho; 2005 Jul; 63 Suppl 7():640-2. PubMed ID: 16111356
    [No Abstract]   [Full Text] [Related]  

  • 5. Autoantibodies against "nuclear dots" in primary biliary cirrhosis.
    Szostecki C; Guldner HH; Will H
    Semin Liver Dis; 1997 Feb; 17(1):71-8. PubMed ID: 9089912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic and clinical utility of antibodies against the nuclear body promyelocytic leukaemia and Sp100 antigens in patients with primary biliary cirrhosis.
    Mytilinaiou MG; Meyer W; Scheper T; Rigopoulou EI; Probst C; Koutsoumpas AL; Abeles D; Burroughs AK; Komorowski L; Vergani D; Bogdanos DP
    Clin Chim Acta; 2012 Aug; 413(15-16):1211-6. PubMed ID: 22503841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anti-Sp100 antibody].
    Mori S; Wake H; Liu K; Takahashi HK; Nishibori M
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():711-3. PubMed ID: 20942171
    [No Abstract]   [Full Text] [Related]  

  • 8. [Meta-analysis of anti-GP210 antibody and anti-SP100 antibody detection for diagnosis of primary biliary cirrhosis].
    Deng HM; Hu SL; Chen WX; Huang Y
    Zhonghua Gan Zang Bing Za Zhi; 2016 Jan; 24(1):62-8. PubMed ID: 26983392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of anti-SP100 antibodies in primary biliary cirrhosis. Comparison of ELISA and immunofluorescence.
    Bauer A; Habior A; Kraszewska E
    J Immunoassay Immunochem; 2013; 34(4):346-55. PubMed ID: 23859785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary biliary cirrhosis-specific autoantibodies in patients with systemic sclerosis.
    Mytilinaiou MG; Bogdanos DP
    Dig Liver Dis; 2009 Dec; 41(12):916; author reply 916-7. PubMed ID: 19604733
    [No Abstract]   [Full Text] [Related]  

  • 11. [Humoral autoimmune response to nuclear Sp100 autoantigen in patients with primary biliary cirrhosis].
    Szostecki C; Will H; Guldner HH
    Z Arztl Fortbild (Jena); 1994 Aug; 88(7-8):573-8. PubMed ID: 7856263
    [No Abstract]   [Full Text] [Related]  

  • 12. PBC screen: an IgG/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis.
    Liu H; Norman GL; Shums Z; Worman HJ; Krawitt EL; Bizzaro N; Vergani D; Bogdanos DP; Dalekos GN; Milkiewicz P; Czaja AJ; Heathcote EJ; Hirschfield GM; Tan EM; Miyachi K; Bignotto M; Battezzati PM; Lleo A; Leung PS; Podda M; Gershwin ME; Invernizzi P
    J Autoimmun; 2010 Dec; 35(4):436-42. PubMed ID: 20932720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical relevance of combined anti-mitochondrial M2 detection assays for primary biliary cirrhosis.
    Han E; Jo SJ; Lee H; Choi AR; Lim J; Jung ES; Oh EJ
    Clin Chim Acta; 2017 Jan; 464():113-117. PubMed ID: 27864100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-multiple nuclear dots (anti-MND) and anti-SP100 antibodies in hepatic and rheumatological disorders.
    Muratori P; Muratori L; Cassani F; Terlizzi P; Lenzi M; Rodrigo L; Bianchi FB
    Clin Exp Immunol; 2002 Jan; 127(1):172-5. PubMed ID: 11882049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of two ELISA assays for anti-Sp100 determination.
    Manuel Lucena J; Montes Cano M; Luis Caro J; Respaldiza N; Alvarez A; Sánchez-Román J; Núñez-Roldán A; Wichmann I
    Ann N Y Acad Sci; 2007 Aug; 1109():203-11. PubMed ID: 17785307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antineutrophil nuclear antibodies (ANNA) in primary biliary cirrhosis: their prevalence and antigen specificity.
    Orth T; Gerken G; Meyer Zum Büschenfelde KH; Mayet WJ
    Z Gastroenterol; 1997 Feb; 35(2):113-21. PubMed ID: 9066101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anti-Sp100 and anti-Gp210 in the diagnosis of primary biliary cirrhosis in patients with autoimmune cholangitis].
    Romero Gómez M; Wichmann I; Otero Fernández MA; Suárez García E; Grande L; Núñez J; Nevado Santos M; Castro Fernández M
    Gastroenterol Hepatol; 1999 Jan; 22(1):11-3. PubMed ID: 10089705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specificity and sensitivity of gp210 autoantibodies detected using an enzyme-linked immunosorbent assay and a synthetic polypeptide in the diagnosis of primary biliary cirrhosis.
    Bandin O; Courvalin JC; Poupon R; Dubel L; Homberg JC; Johanet C
    Hepatology; 1996 May; 23(5):1020-4. PubMed ID: 8621127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibodies to the nuclear Sp100 protein in primary biliary cirrhosis and associated diseases: epitope specificity and immunoglobulin class distribution.
    Szostecki C; Will H; Netter HJ; Guldner HH
    Scand J Immunol; 1992 Oct; 36(4):555-64. PubMed ID: 1384113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is prevalence of PBC underestimated in patients with systemic sclerosis?
    Norman GL; Bialek A; Encabo S; Butkiewicz B; Wiechowska-Kozlowska A; Brzosko M; Shums Z; Milkiewicz P
    Dig Liver Dis; 2009 Oct; 41(10):762-4. PubMed ID: 19357001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.